The impact of supplementary narrative-based information on colorectal cancer screening beliefs and intention

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  McGregor, Lesley M ^a   von Wagner, Christian ^a   Vart, Gemma ^a   Yuen, Wing Chee ^a   Raine, Rosalind ^a   Wardle, Jane ^a   Robb, Kathryn A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Beliefs; Cancer screening; Colorectal; Faecal occult blood test; Narratives; UK

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEALTH BELIEF; HUMAN; INFORMATION; MALE; OCCULT BLOOD; QUESTIONNAIRE; SCREENING TEST; SELF CONCEPT; SUPPLEMENTARY NARRATIVE INFORMATION; UNITED KINGDOM; ATTITUDE TO HEALTH; BEHAVIOR; COLORECTAL NEOPLASMS; CULTURAL ANTHROPOLOGY; EARLY CANCER DIAGNOSIS; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RANDOMIZATION; RISK FACTOR; VERBAL COMMUNICATION;

ADULT; COLORECTAL NEOPLASMS; CULTURE; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MALE; MIDDLE AGED; NARRATION; RANDOM ALLOCATION; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84927712792     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1167-3     Document Type: Article

References (40)

1. American Cancer Society. Cancer facts and figures 2015. [http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/index]
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-403.
3. Diaz JA, Slomka T. State of the art review: colorectal cancer screening. Am J Lifestyle Med. 2012;6:196-203.
4. World Health Organization (Europe). Action plan for implementation of the European strategy for the prevention and control of noncommunicable diseases 2012-2016 [http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/publications/2012/action-plan-for-implementation-of-the-european-strategy-for-the-prevention-and-control-of-noncommunicable-diseases-20122016]
5. Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer. 2012;107:255-9.
6. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2012;61:1036-40.
7. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770-80.
8. Libby G, Bray J, Champion J, Brownlee LA, Birrell J, Gorman DR, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomised controlled trial. J Med Screen. 2011;18:24-9.
9. Tseng DS, Cox E, Plane MB, Hla KM. Efficacy of patient letter reminders on cervical cancer screening: a meta analysis. J Gen Intern Med. 2001;16:563-8.
10. Wagner TH. The effectiveness of mailed patient reminders on mammography screening: A meta-analysis. Am J Prev Med. 1998;14:64-70.
11. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712-8.
12. Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35:285-94.
13. Witte K. Putting the fear back into fear appeals: The extended parallel process model. Commun Monogr. 1992;59:329-49.
14. Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cacner using faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66:2425-35.
15. Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38:508-16.
16. van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AHC, Reijerink JCIY, et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer. 2013;49:2321-30.
17. Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705-11.
18. Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008;8:34.
19. Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative health communication and behavior change: the influence of exemplars in the news on intention to quit smoking. J Commun. 2012;62:473-92.
20. Green MC. Narratives and cancer communication. J Commun. 2006;56:S163-83.
21. Kreuter MW, Green M, Cappella J, Slater M, Wise M, Storey D, et al. Narrative communication in cancer prevention and control: A framework to guide research and application. Ann Behav Med. 2007;33:221-35.
22. Miller-Day M, Hecht ML. Narrative means to preventative ends: a narrative engagement framework for designing prevention interventions. Health Commun. 2013;28:657-70.
23. Kreuter MW, Holmes K, Alcaraz K, Kalesan B, Rath S, Richert M, et al. Comparing narrative and informational videos to increase mammography in low-income African American women. Patient Educ Couns. 2010;81:S6-14.
24. Dillard AJ, Fagerlin A, Cin SD, Zikmund-Fisher BJ, Ubel PA. Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. Soc Sci Med. 2010;71:45-52.
25. Jensen JD, King AJ, Carcioppolo N, Krakow M, Samadder NJ, Morgan S. Comparing tailored and narrative worksite interventions at increasing colonoscopy adherence in adults 50-75: a randomized controlled trial. Soc Sci Med. 2014;104:31-40.
26. Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol. 2003;22:99-105.
27. Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol. 2004;4:26.
28. Bowel Cancer Screening. The Facts [http://www.cancerscreening.nhs.uk/bowel/publications/the-facts.html]
29. Shaffer VA, Zikmund-Fisher BJ. All stories are not alike: a purpose-, content-, and valence-based taxonomy of patient narratives in decision aids. Med Decis Making. 2012;33:4-13.
30. Dillard AJ, Main JL. Using a health message with a testimonial to motivate colon cancer screening: associations with perceived identification and vividness. Health Educ Behav. 2013;40:673-82.
31. Helitzer D, Hollis C, Cotner J, Oestreicher N. Health literacy demands of written health information material: an assessment of cervical cancer prevention materials. Cancer Control. 2009;16(1):70-8.
32. Dillard AJ, Ferrer RA, Ubel PA, Fagerlin A. Risk perception measures' association with behavior intentions, affect, and cognition following colon cancer screening messages. Health Psych. 2012;31:106-13.
33. Rawl S, Champion V, Menon U, Loehrer PJ, Vance GH, Skinner CS. Validation of scales to measure benefits of and barriers to colorectal cancer screening. J Psychosoc Oncol. 2001;19:47-63.
34. Wardle J, McCaffery K, Nadel M, Atkin W. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004;59:249-61.
35. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Meth Ins C. 2004;36:717-31.
36. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879-91.
37. Rosenstock IM. Why people use health services. Milbank Meml Fund Q. 1966;44:94-124.
38. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191-215.
39. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Brit J Cancer. 2011;105:475-80.
40. Reeder AI. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators. The New Zeal Med J. 2011;124:11-7.